Journal of the American College of Cardiology
-
J. Am. Coll. Cardiol. · Sep 2013
Randomized Controlled Trial Multicenter StudyA multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.
The purpose of this study was to assess the effects of qili qiangxin capsules in patients with chronic heart failure (CHF). ⋯ On a background of standard treatment, qili qiangxin capsules further reduced the levels of NT-proBNP. Together, our data suggest that qili qiangxin capsules could be used in combination therapy for CHF.
-
J. Am. Coll. Cardiol. · Sep 2013
Randomized Controlled Trial Multicenter StudyIntensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.
The study sought to test whether high-dose statin treatment would result in greater reductions in plaque inflammation than low-dose statins, using fluorodeoxyglucose-positron emission tomography/computed tomographic imaging (FDG-PET/CT). ⋯ Statin therapy produced significant rapid dose-dependent reductions in FDG uptake that may represent changes in atherosclerotic plaque inflammation. FDG-PET imaging may be useful in detecting early treatment effects in patients at risk or with established atherosclerosis.
-
J. Am. Coll. Cardiol. · Sep 2013
Letter Multicenter Study Comparative Study Controlled Clinical TrialDouble versus standard loading dose of ticagrelor: onset of antiplatelet action in patients with STEMI undergoing primary PCI.